The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica

More is less: Glucocorticoid-sparing agents in polymyalgia rheumatica
Andriko Palmowski, Frank Buttgereit, Anja Strangfeld +1
Therapeutic Advances in Musculoskeletal Disease15 Sep 2026Peer-reviewedCC BY 4.0Full textGeneral medicinePMCEurope PMC
P076 Spontaneous remission of polymyalgia rheumatica without treatment
Tony Yap, Mariam Malik
Rheumatology advances in practice1 Nov 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
Polymyalgia Rheumatica or Something Else? Bilateral Shoulder, Arm, and Thigh Pain with Diffuse Marrow Edema Revealing B-cell Acute Lymphoblastic Leukemia
Kazuya Matsumoto, Yoshinori Matsumoto, Shoichi Nawachi +13
Internal Medicine8 Aug 2026Peer-reviewedCC BY-NC-NDFull textEpidemiology & public healthJ-STAGE
Imaging for diagnosis, monitoring and outcome prediction in polymyalgia rheumatica: a systematic literature review and meta-analysis informing an international task force
Sofia Ramiro, Louise Falzon, Christian Dejaco +5
RMD Open23 Oct 2026Peer-reviewedCC BYFull text1 citedGeneral medicineDOAJ
Influence of Sex on Glucocorticoid Toxicity Profiles in Polymyalgia Rheumatica
Megan M. Sullivan, Simran Nimal, Dhara Awasthi +6
ACR Open Rheumatology4 Nov 2026Peer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC

Cite

BibTeX

@article{anon20262026,
  title = {{The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica}},
  journal = {Rheumatology (Oxford, England)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13661133},
  note = {CC BY-NC},
}

RIS

TY  - JOUR
TI  - The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica
PY  - 2026
DA  - 2026/10/01
JO  - Rheumatology (Oxford, England)
UR  - https://europepmc.org/article/PMC/PMC13661133
SN  - 1462-0324
SN  - 1462-0332
ER  -

Related

Cite